Maria Valsecchi to Recurrence
This is a "connection" page, showing publications Maria Valsecchi has written about Recurrence.
Connection Strength
0.256
-
New concepts on the clinical course and stratification of compensated and decompensated cirrhosis. Hepatol Int. 2018 Feb; 12(Suppl 1):34-43.
Score: 0.083
-
Crude incidence in two-phase designs in the presence of competing risks. BMC Med Res Methodol. 2016 Jan 11; 16:5.
Score: 0.075
-
Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study. Eur J Cancer. 2019 11; 122:61-71.
Score: 0.024
-
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols. Haematologica. 2020 07; 105(7):1887-1894.
Score: 0.024
-
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols. Br J Haematol. 2018 09; 182(5):705-711.
Score: 0.022
-
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000). J Clin Oncol. 2018 01 20; 36(3):244-253.
Score: 0.021
-
A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group. Br J Haematol. 2002 Sep; 118(3):741-7.
Score: 0.007